Closing arguments in Rosenberg v. Merck were heard today in Atlantic City, New Jersey. Defense attorney Christy Jones, of Butler Snow, went first.
0 Comments Click here to read/write comments
Topics: Products Liability, Pharmaceutical, In re: Fosamax
South Carolina v. Janssen Pharmaceutica, scheduled to begin February 14 in Spartanburg, South Carolina, will be the third jury trial involving claims that Johnson & Johnson overcharged for its antipsychotic drug Risperdal (generically known as "Risperdone"). South Carolina's alleged Medicaid overcharge damages are said to run into the billions.
Pennslyvania asserted a simlar claim, but the case was dismissed in June, 2010, after the state had presented its evidence to a jury. But in Louisiana a jury awarded $257M against Johnson & Johnson last October, and in 2009 a West Virginia judge awarded $4.4M in damages. Several other states' Risperdal claims are still pending, including Arkansas, Montana, New Mexico, Texas, and Utah.
0 Comments Click here to read/write comments
Topics: Pharmaceutical, Commercial Law, SC v. Janssen Pharmaceutica
Opening statements were heard today in the first state court Fosamax products liability trial, Rosenberg v. Merck.
0 Comments Click here to read/write comments
Topics: Toxic Torts, Products Liability, Pharmaceutical, In re: Fosamax
Watch CVN's live webcast of the first state-court Fosamax trial, which begins next week in Atlantic City, New Jersey, before Hon. Judge Carol Higbee.
0 Comments Click here to read/write comments
Topics: Toxic Torts, Products Liability, Pharmaceutical, In re: Fosamax
Hon. Judge Julie O'Kane declared a mistrial in Torrence v. Pfizer, after the defense showed the jury prejudicial evidence that had not been admitted.
0 Comments Click here to read/write comments
Topics: Negligence, Pharmaceutical, Malpractice
